2017 Q2 Form 10-Q Financial Statement

#000162828017007149 Filed on July 20, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $4.310M $2.647M
YoY Change 62.8% 116.12%
Cost Of Revenue $2.639M $1.572M
YoY Change 67.86% 164.25%
Gross Profit $1.671M $1.075M
YoY Change 55.4% 70.66%
Gross Profit Margin 38.76% 40.61%
Selling, General & Admin $4.165M $4.125M
YoY Change 0.97% 38.08%
% of Gross Profit 249.28% 383.66%
Research & Development $877.6K $1.128M
YoY Change -22.19% 14.82%
% of Gross Profit 52.53% 104.91%
Depreciation & Amortization $70.00K $60.00K
YoY Change 16.67% -14.29%
% of Gross Profit 4.19% 5.58%
Operating Expenses $5.042M $5.252M
YoY Change -4.0% 32.32%
Operating Profit -$3.372M -$4.177M
YoY Change -19.29% 25.09%
Interest Expense $130.0K $80.00K
YoY Change 62.5% -96.26%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.240M -$4.100M
YoY Change -20.98% 241.67%
Income Tax
% Of Pretax Income
Net Earnings -$3.238M -$4.096M
YoY Change -20.94% 240.38%
Net Earnings / Revenue -75.12% -154.7%
Basic Earnings Per Share -$2.49
Diluted Earnings Per Share -$2.49 -$68.33M
COMMON SHARES
Basic Shares Outstanding 1.302M shares
Diluted Shares Outstanding 1.302M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.610M $11.33M
YoY Change -68.14% -10.36%
Cash & Equivalents $3.612M $11.33M
Short-Term Investments
Other Short-Term Assets $1.720M $1.070M
YoY Change 60.75% 94.55%
Inventory $1.477M $1.050M
Prepaid Expenses
Receivables $984.5K $330.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.794M $13.78M
YoY Change -43.44% -8.13%
LONG-TERM ASSETS
Property, Plant & Equipment $444.3K $610.0K
YoY Change -27.16% -24.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $140.0K $180.0K
YoY Change -22.22% -18.18%
Total Long-Term Assets $588.9K $800.0K
YoY Change -26.39% -22.33%
TOTAL ASSETS
Total Short-Term Assets $7.794M $13.78M
Total Long-Term Assets $588.9K $800.0K
Total Assets $8.383M $14.58M
YoY Change -42.51% -9.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $758.2K $640.0K
YoY Change 18.47% -27.27%
Accrued Expenses $1.747M $1.850M
YoY Change -5.59% -1.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.670M $2.910M
YoY Change 26.1% -13.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.00K $110.0K
YoY Change -63.64% -89.52%
Total Long-Term Liabilities $40.00K $110.0K
YoY Change -63.64% -89.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.670M $2.910M
Total Long-Term Liabilities $40.00K $110.0K
Total Liabilities $3.711M $3.015M
YoY Change 23.09% -31.64%
SHAREHOLDERS EQUITY
Retained Earnings -$184.9M -$171.8M
YoY Change 7.68%
Common Stock $165.00 $492.00
YoY Change -66.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.672M $11.56M
YoY Change
Total Liabilities & Shareholders Equity $8.383M $14.58M
YoY Change -42.5% -9.06%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$3.238M -$4.096M
YoY Change -20.94% 240.38%
Depreciation, Depletion And Amortization $70.00K $60.00K
YoY Change 16.67% -14.29%
Cash From Operating Activities -$3.260M -$4.180M
YoY Change -22.01% 17.75%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$30.00K
YoY Change 33.33% -90.63%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$30.00K
YoY Change 33.33% -90.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 6.800M
YoY Change -99.85% -32.74%
NET CHANGE
Cash From Operating Activities -3.260M -4.180M
Cash From Investing Activities -40.00K -30.00K
Cash From Financing Activities 10.00K 6.800M
Net Change In Cash -3.290M 2.590M
YoY Change -227.03% -58.49%
FREE CASH FLOW
Cash From Operating Activities -$3.260M -$4.180M
Capital Expenditures -$40.00K -$30.00K
Free Cash Flow -$3.220M -$4.150M
YoY Change -22.41% 28.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
nuro Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
318761 USD
nuro Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
0 USD
CY2016Q4 nuro Technology Fees
TechnologyFees
450000 USD
CY2017Q2 nuro Technology Fees
TechnologyFees
450000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
734048 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
758208 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001289850
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1860519 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
NeuroMetrix, Inc.
dei Trading Symbol
TradingSymbol
NURO
CY2016Q4 nuro Accrued Sales Return Provisions
AccruedSalesReturnProvisions
488200 USD
CY2017Q2 nuro Accrued Sales Return Provisions
AccruedSalesReturnProvisions
413871 USD
CY2016Q4 nuro Clinical Study Obligations
ClinicalStudyObligations
25000 USD
CY2017Q2 nuro Clinical Study Obligations
ClinicalStudyObligations
104000 USD
CY2016Q1 nuro Closing Price Of Shares
ClosingPriceOfShares
14.32
CY2016Q4 nuro Common Stock Warrants
CommonStockWarrants
4641 USD
CY2017Q2 nuro Common Stock Warrants
CommonStockWarrants
41099 USD
CY2016Q4 nuro Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
4641 USD
CY2017Q2 nuro Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
41099 USD
nuro Fair Value Adjustmentof Warrants Repricing
FairValueAdjustmentofWarrantsRepricing
0 USD
nuro Fair Value Adjustmentof Warrants Repricing
FairValueAdjustmentofWarrantsRepricing
244611 USD
CY2017Q2 nuro Restricted Cash Collateral Letters Of Credit
RestrictedCashCollateralLettersOfCredit
507381 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
738729 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
984515 USD
CY2016Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
28100 USD
CY2017Q2 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
115400 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1648731 USD
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1746556 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
390800 USD
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
363000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183439463 USD
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1650519 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189620780 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000 USD
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3020129 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2750452 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8826211 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7760047 shares
CY2016Q4 us-gaap Assets
Assets
8283891 USD
CY2017Q2 us-gaap Assets
Assets
8382659 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
7586923 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
7793787 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12462872 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11330857 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3949135 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3611949 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1132015 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-337186 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
836862 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1650519 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
836862 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10147721 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1268440 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
84 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
165 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
1572370 USD
us-gaap Cost Of Revenue
CostOfRevenue
3054883 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
2639402 USD
us-gaap Cost Of Revenue
CostOfRevenue
5337004 USD
CY2016Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
910595 USD
CY2017Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
1276207 USD
CY2016Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
1247545 USD
CY2017Q2 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
2031262 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
628236 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
659273 USD
us-gaap Depreciation
Depreciation
124396 USD
us-gaap Depreciation
Depreciation
126254 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-42.98
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-52.49
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.49
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.12
us-gaap Interest And Other Income
InterestAndOtherIncome
11258 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-77309 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
307471 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
505553 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
461547 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-171625 USD
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-130552 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-208153 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1292305 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2716646 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1245347 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2667129 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
1075052 USD
us-gaap Gross Profit
GrossProfit
1867786 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
1670657 USD
us-gaap Gross Profit
GrossProfit
3279177 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-356769 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24160 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-413733 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
245786 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
235924 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
295907 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
185132 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
31037 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-41031 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
225089 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
198543 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
53464 USD
CY2016Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
4553 USD
CY2017Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
3207 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
7464 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
630361 USD
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
704607 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
1252238 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
1477327 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
466906 USD
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
772720 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
154971 USD
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0 USD
CY2016Q4 us-gaap Liabilities
Liabilities
3323127 USD
CY2017Q2 us-gaap Liabilities
Liabilities
3710689 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8283891 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8382659 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3318486 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3669590 USD
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2018-01-15
CY2017Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2500000 USD
CY2017Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6719315 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6312378 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-55823 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-37869 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7795507 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6611695 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-4095520 USD
us-gaap Net Income Loss
NetIncomeLoss
-8190775 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-3237796 USD
us-gaap Net Income Loss
NetIncomeLoss
-6470196 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23941897 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28037152 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3237796 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10511878 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
5252434 USD
us-gaap Operating Expenses
OperatingExpenses
10241444 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
5042212 USD
us-gaap Operating Expenses
OperatingExpenses
9964990 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4177382 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8373658 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3371555 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6685813 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
220752 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
201999 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2016Q4 us-gaap Other Deferred Credits Current
OtherDeferredCreditsCurrent
619309 USD
CY2017Q2 us-gaap Other Deferred Credits Current
OtherDeferredCreditsCurrent
1371989 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55823 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37869 USD
CY2016Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
19846377 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
19846377 USD
CY2017Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4041682 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1646821 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1719996 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
164262 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
144551 USD
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
6719315 USD
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
6312378 USD
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
45879 USD
CY2017Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
98286 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
532706 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
444321 USD
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
488200 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
413871 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1127850 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2284640 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
877584 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1780868 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178478801 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-184900000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-184948997 USD
CY2016Q2 us-gaap Revenues
Revenues
2647422 USD
us-gaap Revenues
Revenues
4922669 USD
CY2017Q2 us-gaap Revenues
Revenues
4310059 USD
us-gaap Revenues
Revenues
8616181 USD
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2832279 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5240158 USD
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2919281 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5516993 USD
us-gaap Share Based Compensation
ShareBasedCompensation
121989 USD
us-gaap Share Based Compensation
ShareBasedCompensation
113635 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
4960764 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
4671970 USD
CY2017Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.125
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
557089 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
534192 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1302231 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1152441 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001628280-17-007149-index-headers.html Edgar Link pending
0001628280-17-007149-index.html Edgar Link pending
0001628280-17-007149.txt Edgar Link pending
0001628280-17-007149-xbrl.zip Edgar Link pending
a10q6302017document.htm Edgar Link pending
a10q6302017exhibit311.htm Edgar Link pending
a10q6302017exhibit312.htm Edgar Link pending
a10q6302017exhibit32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nuro-20170630.xml Edgar Link completed
nuro-20170630.xsd Edgar Link pending
nuro-20170630_cal.xml Edgar Link unprocessable
nuro-20170630_def.xml Edgar Link unprocessable
nuro-20170630_lab.xml Edgar Link unprocessable
nuro-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending